A detailed history of Key F Inancial Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Key F Inancial Inc holds 2 shares of TXG stock, worth $32. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 2 -0.0%
Holding current value
$32
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 19, 2022

BUY
$135.05 - $182.59 $270 - $365
2 New
2 $0

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.54B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Key F Inancial Inc Portfolio

Follow Key F Inancial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.